Niche MRI developer InnerVision MRI of London, U.K., has received510(k) clearance for its Ortho 8000 0.14-tesla permanent magnetsystem. InnerVision has targeted the system at orthopedic, pediatric,and interventional uses (SCAN 8/30/95). Ortho 8000 will
Niche MRI developer InnerVision MRI of London, U.K., has received
510(k) clearance for its Ortho 8000 0.14-tesla permanent magnet
system. InnerVision has targeted the system at orthopedic, pediatric,
and interventional uses (SCAN 8/30/95). Ortho 8000 will be sold
in the U.S. by Vision Medical Services, and will be shown in Vision's
booth at next month's Radiological Society of North America meeting.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.